Eli Lilly and Company (NYSE:LLY) (NYSE:LLY) is a global pharmaceutical company renowned for its commitment to research and development of innovative therapies. Founded in 1876 by Colonel Eli Lilly in Indianapolis, Indiana, the company has evolved into one of the world’s leading developers of prescription medicines. Its primary business activities encompass discovery, development, manufacturing and commercialization of a broad range of pharmaceutical products targeting critical disease areas.
Lilly’s product portfolio spans several therapeutic categories, including endocrinology, immunology, oncology, neuroscience and cardiovascular health. The company is particularly recognized for its leadership in diabetes care, offering insulin and non-insulin therapies designed to improve patient outcomes. In oncology, Lilly has advanced treatments such as targeted therapies and immuno-oncology agents. Its neuroscience pipeline focuses on conditions like Alzheimer’s disease and migraine, while immunology offerings address autoimmune disorders such as rheumatoid arthritis and psoriasis.
Research and development is a cornerstone of Lilly’s strategy, with significant investments directed toward delivering first-in-class and best-in-class medicines. The company maintains a global network of research centers and collaborates with academic institutions, biotechnology firms and nonprofit organizations to accelerate scientific breakthroughs. In recent years, Lilly has expanded its R&D footprint in the United States, Europe and Asia, reflecting its ambition to bring novel therapies to patients worldwide.
Operating in more than 120 countries, Eli Lilly and Company manages a diverse array of manufacturing facilities, distribution sites and commercial offices to support its global supply chain and ensure product availability. Led by President and CEO David A. Ricks, the company emphasizes corporate responsibility through initiatives in sustainability, integrity and patient access programs. With a history of over 140 years, Lilly continues to focus on addressing unmet medical needs and enhancing health outcomes across the globe.
